Ares Financial Consulting
HALO icon

Ares Financial Consulting’s Halozyme HALO Stock Holding History

Ares Financial Consulting’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$17K Hold
154
– – 0.01% 449
2026
Q2 		$12.1K Hold
154
– – 0.01% 533
2026
Q1 		$10.1K Hold
154
– – 0.01% 543
2025
Q4 		$10.4K Buy
+154
New +$10.4K 0.01% 356

Other funds holding HALO

Boston Partners
Boston Partners Boston, Massachusetts $111B AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Congress Asset Management
Congress Asset Management Boston, Massachusetts $15.4B AUM 30.39% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.8B AUM 33.92% 1-Year Est. Return
Los Angeles Capital Management
Los Angeles Capital Management Los Angeles, California $29.2B AUM 33.64% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $54.1B AUM 39.29% 1-Year Est. Return
Stephens Investment Management Group
Stephens Investment Management Group Houston, Texas $9.29B AUM 41.16% 1-Year Est. Return
GW&K Investment Management
GW&K Investment Management Boston, Massachusetts $11.8B AUM 29.45% 1-Year Est. Return

Ares Financial Consulting's HALO Position: Q3 2026 in Review

Ares Financial Consulting held its Halozyme (HALO) position steady in Q3 2026 at 154 shares worth $17K. The position accounts for 0.01% of the portfolio, ranked #449.

Ares Financial Consulting first reported a position in HALO in Q4 2025 and has held it in 4 quarters since. 456 funds tracked by Wall St. Rank hold HALO as of Q3 2026.

  • Ares Financial Consulting held 154 shares of Halozyme worth $17K as of Q3 2026.
  • Ares Financial Consulting left its Halozyme share count unchanged in Q3 2026.
  • Halozyme made up 0.01% of Ares Financial Consulting's portfolio in Q3 2026, its #449 holding.
  • Ares Financial Consulting first reported a position in Halozyme in Q4 2025 and has held it in 4 quarters since.
  • 456 funds tracked by Wall St. Rank held Halozyme as of Q3 2026.

Based on Ares Financial Consulting's 13F filing for Q3 2026, filed 19 Oct 2026.